未找到相关数据
Phase 1 dose escalation study of MH048, a novel and non-covalent BTK inhibitor in patients with relapsed or refractory B-cell malignancies.
被引：0
作者：
Cao, Guoqing
Jin, Zhengming
Li, Yuhua
Zhang, Liling
Shi, Junwei
Jin, Jie
机构：
[1] Minghui Pharmaceut Shanghai LTD, Shanghai, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Hematol, Suzhou, Peoples R China
[3] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Peoples R China
[4] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[6] Zhejiang Univ, Sch Med, Dept Hematol, Affiliated Hosp 1, Hangzhou, Peoples R China
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7547
引用
收藏
页数：1
相关论文